4//SEC Filing
LI WILLIAM 4
Accession 0001104659-23-041750
CIK 0001509745other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 8:14 PM ET
Size
5.7 KB
Accession
0001104659-23-041750
Insider Transaction Report
Form 4
LI WILLIAM
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+150,000→ 150,000 totalExercise: $0.34Exp: 2033-03-31→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001273806
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 8:14 PM ET
- Size
- 5.7 KB